Jonathan Zippin, M.D., Ph.D.
A great academic department should include a group of physicians who not only care deeply for their patients but also for their colleagues, and provide an environment that promotes learning and collaboration, which in turn leads to better patient care. In our department, dedication to patient care is combined with a core interest in both clinical and basic research, which allows our physicians to contribute to the better understanding of diseases and provide their patients with the most up-to-date therapies. Because Weill Cornell's Department of Dermatology embodies these qualities of medical care, I am honored to be a member of its faculty.
Jonathan Hale Zippin M.D., Ph.D. is an Assistant Attending Dermatologist and Assistant Professor of Dermatology at Weill Medical College of Cornell. Dr. Zippin attended Cornell University where he received a Bachelor's of Science with Honors. He then attended the Rockefeller/Cornell/Sloan-Kettering Tri-Institutional M.D./Ph.D. program. He completed his general medicine internship at the Mount Sinai Hospital in New York City, followed by a residency in dermatology at the Weill Cornell Medical Center - New York Presbyterian Hospital.
Dr. Zippin is a member of the American Academy of Dermatology, the American Society of Dermatologic Surgery, and the American Contact Dermatitis Society. He is also a member of the medical editorial board of the Journal of Drugs in Dermatology.
Dr. Zippin has authored numerous peer-reviewed publications in the area of signal transduction and skin disease, and has published a variety of papers reviewing the treatment of dermatologic diseases.
To schedule an appointment, please call 646-962-DERM (3376).
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.
* indicates this physician is no longer accepting new patients with this insurance plan.
- AETNA [HMO]
- AETNA [PPO]
- AETNA [Medicare]
- Aetna - Weill Cornell [POS]
- Affinity Essential
- Blue Priority Network
- Emblem Select Care
- Empire Blue Cross/Blue Shield [Pathway X]
- Empire Blue Cross/Blue Shield [PPO]
- Empire Blue Cross/Blue Shield [Pathway X Enhanced]
- Empire Blue Cross/Blue Shield [EPO]
- Empire Blue Cross/Blue Shield [HMO]
- Empire Blue Cross/Blue Shield [Mediblue (Senior)]
- Fidelis Care
- GHI [CBP]
- Health Insurance Plan of NY (HIP) [Medicare]
- Health Insurance Plan of NY (HIP) [Medicaid]
- Health Insurance Plan of NY (HIP)
- Health Plus - Amerigroup [CHP]
- Health Plus - Amerigroup
- Health Republic
- Oxford Health Plans [Medicare Advantage]
- Oxford Health Plans [Freedom]
- Oxford Health Plans [Liberty]
- Rockefeller University - CoreSource
- UHC Compass
- United Empire
- United Health Care [Medicare]
- United Health Care
- United Health Care [Community Plan]
- VNSNY CHOICE Medicare [Medicare]
- VNSNY CHOICE Medicare [HMO]
Zippin JH, Chadwick P, Levin LR, Buck J, and Magro C. (2010) "Soluble adenylyl cyclase defines a nuclear cAMP microdomain in keratinocyte hyperproliferative skin diseases" J Invest Dermatol. May;130(5):1279-87.
Zippin JH, Friedman A. (2009) "Nanotechnology in cosmetics and sunscreens: an update" J Drugs Dermatol. Oct;8(10):955-8
Mazza JM, Zippin JH. (2009) "Alpha-melanocyte stimulating hormone analogues: the perils and the promise" J Drugs Dermatol. Aug;8(8):772-6.
Han G, Zippin JH, Friedman A. (2009) "From bench to bedside: the therapeutic potential of nitric oxide in dermatology" J Drugs Dermatol. Jun;8(6):586-94.
Goh C and Zippin JH (2009) "Androgenetic Alopecia: Diagnosis and treatment with a focus on recent genetic implications" J Drugs Dermatol. Feb; 8(2):185-92.
Ebede T and Zippin JH (2008) "Varicella Virus and the Herpes Zoster Vaccine: A Review of Zostavax and the new AFIP Recommendations" J Drugs Dermatol.. Dec; 7(11):1173-6.
Watkins SA and Zippin JH (2008) "When Wound Healing Goes Awry: A review of normal and abnormal wound healing, scar pathophysiology, and therapeutics" J Drugs Dermatol. Oct; 7(10):2-10.
Ramos LS*, Zippin JH*, Kamenetsky M, Buck J, and Levin LR. (2008) "Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells" J Gen Physiol. 132(3):329-38. Highlighted in J Cell Biol. as recent article of interest Aug 2008; 182: i10.
Wu K, Zippin JH, Huron DR, Kamenetsky M, Hengst U, Buck J, Levin LR, and Jaffrey SR. (2006) "Soluble adenylyl cyclase is required for netrin-1 signaling in nerve growth cones" Nat Neurosci. Oct; 9:1257-64
Stessin AM, Zippin JH, Kamenetsky M, Hess KC, Levin LR, and Buck J. (2006) "Soluble adenylyl cyclase mediates nerve growth factor-induced activation of rap1" J Biol Chem. Jun 23; 281:17253-8.
Hess KC, Jones BH, Marquez B, Chen YQ, Ord TS, Kamenetsky M, Miyamoto C, Zippin JH, Kopf GS, Suarez SS, Levin LR, Williams CJ, Buck J, and Moss SB. (2005) "Bicarbonate responsive 'Soluble' adenylyl cyclase is responsible for multiple specific signaling events in mammalian sperm required for fertilization" Developmental Cell. Aug; 9:1-11
Zippin JH, Farrell J, Huron D, Kamenetsky M, Hess KC, Fischman D, Levin LR and Buck J (2004) "Bicarbonate-responsive 'soluble' adenylyl cyclase defines a cAMP signaling microdomain" J Cell Biol. Feb 16;164(4):527-34. Highlighted as Editor's choice for paper of the week (Sci. STKE, Vol. 2004, Issue 221, pp. tw67) and in a news and views by Richard A. Bundey and Paul A. Insel (Sci. STKE 2004 (231), pe19) in Science's Signal Transduction Knowledge Environment (STKE).
Zippin JH, Chen Y, Nahirney P, Kamenetsky M, Wuttke MS, Fischman DA, Levin LR, Buck J. (2002) "Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains". FASEB J. Jan; 17(1):82-84.
Zippin JH, Levin LR, Buck J (2001). "CO2/HCO3- responsive soluble adenylyl cyclase as a putative metabolic sensor." Trends in Endocrinology and Metabolism 12(8): 366-70. Review
Schatz GW, Reinking J, Zippin J, Nicholson LK, Vogt VM (2001). "Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function." J. Virol. 75(10): 4761-70.
Honors and Awards
2010 Dermatology Foundation Career Development Award
2010 American Skin Association Research Grant
2010 Women's Dermatologic Society Research Grant
2010 LaRoche-Posay Research Award
2009 American Academy of Dermatology, Everett C. Fox, MD Award
2008 New York Academy of Medicine Resident Research Symposium Award
2005 Irving Weinstein Lectureship Award
2004 Julian R. Rachele prize for publication of the year, Weill Cornell Graduate School
2004 The Barbara and Stephen Friedman Fellowship Endowment
2004 Dr. Ezekiel Marion Foster Medical Scientist Fellowship
2002-2003 American Diabetes Association, Medical Scholar
2002 Associated Medical Schools of New York, Medical Scholars Award Winner
1997 Avon Foundation Research Scholar
1994 Semi-Finalist in the 53rd Westinghouse Science Talent Search
- Cosmetic Dermatology
- Dermatology, General
- Skin Tumor
- Skin Cancer
- Contact Dermatitis
- Laser Surgery
- Sexually Transmitted Disease (STD)
- Laser Surgery For Vascular Lesions
- Laser For Leg Veins
- Laser Tattoo Removal
- Laser For Hair Removal
- Chemical Peels
- Restylane Treatment
- Juvederm Fillers
- Sculptra Filler Injection
- Ph.D., Weill Graduate School of Medical Sciences of Cornell University, 2005
- M.D., Weill Cornell Medical College, Cornell University, 2006